Home › Funds › BECK MACK & OLIVER LLC › TEVA
BECK MACK & OLIVER LLC position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
BECK MACK & OLIVER LLC reported holding 1,043,175 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$41.3M, representing 0.89% of its reported portfolio and ranking #32 among its reported holdings. BECK MACK & OLIVER LLC has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How BECK MACK & OLIVER LLC's TEVA position evolved
BECK MACK & OLIVER LLC first disclosed a stake in TEVA in Q3 2023 at 3,177,112 shares (US$32.4M). The position peaked in Q3 2026 at 1,043,175 shares, worth US$41.3M. Across 13 filings, BECK MACK & OLIVER LLC increased the stake 1 time(s), trimmed it 9 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,043,175 shares valued at US$41.3M — a reduction of -14,200 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2024 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.18M | $32.41M | New |
| Q4 2023 | 2.43M | $25.39M | Reduce |
| Q1 2024 | 1.89M | $26.72M | Reduce |
| Q2 2024 | 1.31M | $21.24M | Reduce |
| Q3 2024 | 1.23M | $22.23M | Reduce |
| Q4 2024 | 1.20M | $26.39M | Reduce |
| Q1 2025 | 1.17M | $17.99M | Reduce |
| Q2 2025 | 1.10M | $18.42M | Reduce |
| Q3 2025 | 1.10M | $22.16M | Hold |
| Q4 2025 | 1.06M | $32.97M | Reduce |
| Q1 2026 | 1.05M | $31.68M | Hold |
| Q2 2026 | 1.06M | $35.82M | Add |
| Q3 2026 | 1.04M | $41.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TEVA and 13F data
TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 48 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TEVA
- BANK OF MONTREAL /CAN/ 1.13M sh · $4.53B · Q3 2026
- Phoenix Financial Ltd. 42.63M sh · $1.69B · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 42.25M sh · $1.68B · Q3 2026
- Clal Insurance Enterprises Holdings Ltd 42.01M sh · $1.67B · Q3 2026
- Migdal Insurance & Financial Holdings Ltd. 39.42M sh · $1.56B · Q3 2026
- Harel Insurance Investments & Financial Services Ltd. 34.66M sh · $1.37B · Q3 2026
- Lingotto Investment Management LLP 17.53M sh · $694.38M · Q3 2026
- Altshuler Shaham Ltd 12.43M sh · $499.58M · Q3 2026
- Rubric Capital Management LP 11.57M sh · $458.37M · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 7.57M sh · $299.65M · Q3 2026
- Y.D. More Investments Ltd 6.92M sh · $277.37M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 6.12M sh · $242.31M · Q3 2026
More on BECK MACK & OLIVER LLC
FAQ
How long has BECK MACK & OLIVER LLC held TEVA?
BECK MACK & OLIVER LLC has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BECK MACK & OLIVER LLC's current position in TEVA?
As of Q3 2026, BECK MACK & OLIVER LLC holds 1.04M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $41.31M, representing 0.89% of its reported portfolio and ranking #32.
Has BECK MACK & OLIVER LLC been buying or selling TEVA?
In the latest 13F filing (Q3 2026), BECK MACK & OLIVER LLC reduced its position in TEVA. The position peaked in Q3 2026 at 1.04M shares.
Which other funds hold TEVA?
Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.